PLEKHA4 and neoplasm: The synthetical analysis of CpG methylation and PLEKHA4 performed better than any single index in predicting OS of LGG patients, indicating that these CpG sites can aid LGG tumor progression monitoring and serve as prognostic markers as well, to identify patients with “high-risk”.